My UM
My UM
Search
Research institutes CARIM header image

CARIM - Cardiovascular Research Institute Maastricht

Research Institute

CARIM is one of the top institutes for translational cardiovascular research in Europe. It is among the world leaders in the fields of research into vascular and thrombotic disorders and atrial fibrillation, as well as translational heart failure research. It has also made important international contributions to molecular imaging in the cardiovascular field.

Cardiovascular scientists from around the world have joined CARIM because it values open communication, close cooperation, high ambitions, excellent facilities, and a critical learning environment. 

Research

The research within CARIM is divided into three divisions. Each division consists of more interdisciplinary research programmes, each led by a Principal Investigator (PI). The PIs are responsible for the scientific progress of the programme, the mentoring of PhD students and post-docs, and the financials of the programme.
 

Education

CARIM combines high-level scientific research with high-level education of young researchers, and is therefore qualified as a research school by the Royal Netherlands Academy of Arts and Sciences (KNAW) and recognised as an international training site for Early Stage Researchers by the European Union.

CARIM offers a flexible and integrated education and training programme that suits individual ambitions of our students. The education programme consists of a specialization within the FHML master's programmes in Biomedical Sciences and Physician-Clinical Investigator  (MSc/MD) and a contiguous PhD (doctoral) training programme. 

Divisions

The three divisions within CARIM are:

  • Blood
  • Heart
  • Vessels
Matthijs Cluitmans en Erik Vrij
  • Researchers

Two FHML researchers receive Vidi grants

Matthijs Cluitmans and Erik Vrij both receive a prestigious Vidi grant. Matthijs investigates if AI and computer models can predict sudden cardiac death and Erik uncovers how identical twins arise.
Portretfoto Floor Pinckaers

Catheter treatment is not only effective, but also cost-effective for ischemic stroke

In her doctoral research, Floor Pinckaers examined whether catheter treatment administered within a later time window (6 to 24 hours) is still effective in patients with a cerebral infarction. She also investigated whether this treatment method is cost-effective.
Judith Cosemans

Platelets: more than a band-aid

Platelets do far more than stop bleeding — they also play a role in thrombosis and immune responses. Professor Judith Cosemans studies the various roles platelets fulfil, in order to create personalised treatments for patients and to learn more about blood clotting.
NWO Veni grant

Five FHML researchers receive Veni grants

From stimulating myelin repair in human brain cells to studying how tumours release proteins that trigger muscle breakdown: five innovative FHML research projects receive a Veni.
Athina Vidaki

Creating an identity card with DNA

By looking at just a few letters in your genome, researchers can roughly tell your age, and if you are a smoker or stopped smoking. Athina Vidaki uses these genetic techniques to help solve sexual assault cases.

CARIM works in close cooperation with the Maastricht University Medical Center+ (MUMC+). MUMC+ is known both nationally and internationally for its focus on prevention and taking an integrated approach to health care: from prevention, promotion of good health, and basic care, to top-level clinical diagnostics and treatment. Patient safety is our top priority in all of our endeavours. MUMC+ is part of The Netherlands Federation of University Medical Centres.

Maastricht University Medical Center (MUMC+) logo
Building Faculty of Health. Medicine & Life Sciences
CARIM School for Cardiovascular Diseases
Universiteitssingel 50
6229 ER
Maastricht
Room H 1.362